Pharmaron Beijing Schedules Financial Review Meeting

Pharmaron Beijing Co., Ltd. Class H (HK:3759) has released an update.

Pharmaron Beijing Co., Ltd. has announced a board meeting scheduled for October 29, 2024, to review and approve its financial results for the first nine months of the year. The meeting will involve the company’s board of directors, including executive and non-executive members, under the leadership of Chairman Dr. Lou Boliang. This event is significant for shareholders and potential investors as it will provide insights into the company’s financial health and future prospects.

For further insights into HK:3759 stock, check out TipRanks’ Stock Analysis page.